Oncopeptides AB's total assets for Q2 2025 were kr136.44M, a decrease of -21.32% from the previous quarter. SE:ONCO total liabilities were kr203.32M for the fiscal quarter, a 13.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.